Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥79.81 Million ≈ $11.68 Million USD) by net assets (CN¥3.72 Billion ≈ $543.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300233 market cap for the company's overall valuation and market capitalisation.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Jincheng Pharmaceutical and Chemical Co Ltd ranked by their cash flow conversion efficiency. Explore 300233 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KSL Holdings Bhd
KLSE:5038
|
-0.011x |
|
DBV Technologies S.A.
PA:DBV
|
-0.236x |
|
Groupe Dynamite Inc
TO:GRGD
|
1.361x |
|
Inox Green Energy Services Limited
NSE:INOXGREEN
|
0.015x |
|
Chengdu Jafaantai Technology Co Ltd
SHE:300559
|
-0.020x |
|
V V Food & Beverage Co Ltd
SHG:600300
|
0.083x |
|
MidCap Financial Investment Corporation
NASDAQ:MFIC
|
0.144x |
|
Sinodata Co Ltd
SHE:002657
|
0.002x |
Annual Cash Flow Conversion Efficiency for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. View current stock price of Shandong Jincheng Pharmaceutical and Che for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.72 Billion ≈ $544.93 Million |
CN¥319.64 Million ≈ $46.77 Million |
0.086x | +10.90% |
| 2024-12-31 | CN¥3.83 Billion ≈ $560.76 Million |
CN¥296.59 Million ≈ $43.40 Million |
0.077x | -55.93% |
| 2023-12-31 | CN¥3.78 Billion ≈ $553.29 Million |
CN¥664.08 Million ≈ $97.18 Million |
0.176x | +151.42% |
| 2022-12-31 | CN¥3.66 Billion ≈ $535.47 Million |
CN¥255.63 Million ≈ $37.41 Million |
0.070x | -45.04% |
| 2021-12-31 | CN¥3.44 Billion ≈ $503.30 Million |
CN¥437.19 Million ≈ $63.97 Million |
0.127x | -19.30% |
| 2020-12-31 | CN¥3.47 Billion ≈ $507.37 Million |
CN¥546.13 Million ≈ $79.92 Million |
0.158x | +11.32% |
| 2019-12-31 | CN¥4.08 Billion ≈ $597.74 Million |
CN¥577.98 Million ≈ $84.58 Million |
0.141x | +64.24% |
| 2018-12-31 | CN¥4.09 Billion ≈ $598.21 Million |
CN¥352.20 Million ≈ $51.54 Million |
0.086x | +123.44% |
| 2017-12-31 | CN¥3.94 Billion ≈ $576.20 Million |
CN¥151.83 Million ≈ $22.22 Million |
0.039x | -75.98% |
| 2016-12-31 | CN¥1.50 Billion ≈ $220.11 Million |
CN¥241.48 Million ≈ $35.34 Million |
0.161x | +1.17% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.74 Million |
CN¥207.92 Million ≈ $30.42 Million |
0.159x | -19.26% |
| 2014-12-31 | CN¥1.12 Billion ≈ $163.40 Million |
CN¥219.46 Million ≈ $32.11 Million |
0.197x | +113.78% |
| 2013-12-31 | CN¥1.02 Billion ≈ $149.51 Million |
CN¥93.92 Million ≈ $13.74 Million |
0.092x | +3.55% |
| 2012-12-31 | CN¥975.57 Million ≈ $142.76 Million |
CN¥86.61 Million ≈ $12.67 Million |
0.089x | +35.78% |
| 2011-12-31 | CN¥958.84 Million ≈ $140.31 Million |
CN¥62.69 Million ≈ $9.17 Million |
0.065x | -77.42% |
| 2010-12-31 | CN¥375.33 Million ≈ $54.92 Million |
CN¥108.67 Million ≈ $15.90 Million |
0.290x | -22.83% |
| 2009-12-31 | CN¥281.53 Million ≈ $41.20 Million |
CN¥105.62 Million ≈ $15.46 Million |
0.375x | +168.69% |
| 2008-12-31 | CN¥216.49 Million ≈ $31.68 Million |
CN¥30.23 Million ≈ $4.42 Million |
0.140x | -- |
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.